Scientists make breakthrough in fight against antibiotic resistance

July 29, 2016, University of Sheffield
MRSA
Methicillin-resistant Staphylococcus aureus. Credit: NIH/NIAID

Scientists have developed a pioneering new treatment to prevent bacterial skin infections, which could be used in the battle against 'superbugs', such as MRSA.

The new treatment, developed by researchers at the University of Sheffield in collaboration with AGE UK, is a new way to prevent , such as bed-sores and ulcers, becoming infected.

This new treatment has been proven to work on antibiotic-resistant bacteria, such as MRSA, which is currently one of the biggest threats to global healthcare and medicine.

Bacterial are a major problem for the elderly and people with , such as diabetes. Infected wounds heal more slowly, causing pain and distress for the patient, and are a significant cost to the NHS in the UK.

To launch an infection, bacteria attach tightly to skin cells and have learned to hijack 'sticky patches' on human cells to achieve this. Using proteins called tetraspanins, from , the Sheffield scientists have made these patches much less sticky, allowing bacteria to be harmlessly washed away.

The research has shown that these proteins prevent bacterial infections in a model of , which the scientists say give a clear indication that this treatment is both safe and effective.

This treatment was trialled on a model of 3D tissue engineered skin (TEskin) developed by engineers at the University.

The engineered skin, pioneered by Professor Sheila MacNeil from the University's Department of Materials Science and Engineering, can model infected wounds in human skin and mimics the tissue structure of normal adult skin. It can be used to analyse the penetration of peptides and bacteria.

Dr Pete Monk from the University's Department of Infection, Immunity and Cardiovascular Science, who led the study, said: "This development is a huge breakthrough in the fight against antibiotic-resistance.

"Skin infections, such as bed-sores and ulcers, can be incredibly troubling for patients who may already be dealing with debilitating conditions. They are also a significant problem for modern healthcare.

"We hope that this new therapy can be used to help relieve the burden of infections on both patients and health services while also providing a new insight into how we might defeat the threat of antimicrobial drug resistance.

"The therapy could be administered to patients using a gel or cream and could work well as a dressing. We're hoping it can reach clinical trials stage in the next three to five years."

Unlike conventional antibiotics, the tetraspanin proteins do not directly kill bacteria and so do not encourage the evolution of resistance.

Now, with substantial research funding from the Humane Research Trust, Sheffield scientists are developing the proteins for new anti-bacterial dressings that will help keep wounds sterile and so promote more rapid healing.

This development further cements the University's position at the forefront of world-class research into infectious diseases. Sheffield scientists are developing radical solutions to global problems of disease and antimicrobial resistance as part of projects including Florey and Imagine. These are signature research projects addressing some of the world's biggest biomedical problems.

Explore further: A small molecule outclasses larger ones in combating drug-resistant bacteria that cause skin infections

More information: Jennifer K. Ventress et al. Peptides from Tetraspanin CD9 Are Potent Inhibitors of Staphylococcus Aureus Adherence to Keratinocytes, PLOS ONE (2016). DOI: 10.1371/journal.pone.0160387

Related Stories

A small molecule outclasses larger ones in combating drug-resistant bacteria that cause skin infections

April 6, 2016
A promising drug candidate to address the growing problem of antibiotic-resistant skin infections has been discovered by A*STAR researchers.

Ultrasound accelerates skin healing—especially for diabetics and the elderly

July 13, 2015
Healing times for skin ulcers and bedsores can be reduced by a third with the use of low-intensity ultrasound, scientists from the University of Sheffield and University of Bristol have found.

Narrow wavelength of UV light safely kills drug-resistant bacteria

June 8, 2016
Scientists from the Center for Radiological Research at Columbia University Medical Center have shown that a narrow wavelength of ultraviolet (UV) light safely killed drug-resistant MRSA bacteria in mice, demonstrating a ...

Resistance to antibiotics and to immune system are interconnected in bacteria

June 30, 2016
Antibiotics and the immune system are the two forces that cope with bacterial infections. Now, two studies from Isabel Gordo's laboratory, at Instituto Gulbenkian de Ciência (IGC, Portugal), show for the first time that ...

Recommended for you

Scientists gain new insight on how antibodies interact with widespread respiratory virus

February 22, 2018
Scientists have found and characterized the activity of four antibodies produced by the human immune system that target an important protein found in respiratory syncytial virus (RSV), according to new research published ...

Study reveals how kidney disease happens

February 22, 2018
Monash researchers have solved a mystery, revealing how certain immune cells work together to instigate autoimmune kidney disease.

Past encounters with the flu shape vaccine response

February 20, 2018
New research on why the influenza vaccine was only modestly effective in recent years shows that immune history with the flu influences a person's response to the vaccine.

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.